Cumberland Pharmaceuticals (CPIX) Accounts Payables (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Accounts Payables of $4.5 million for Q1 2026, down 75.83% sequentially from $18.6 million in Q4 2025, and down 67.78% YoY from $13.9 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Accounts Payables (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Accounts Payables for 17 years, with the latest figure at $4.5 million in Q1 2026.
- Quarterly Accounts Payables fell 67.78% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 67.78% YoY) and the FY2025 annual result came in at $18.6 million, changed N/A from the prior year.
- Accounts Payables declined to $4.5 million in Q1 2026 per CPIX's latest filing, from $18.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $18.6 million in Q4 2025 and troughed at $4.5 million in Q1 2026.
- A 5-year average of $12.1 million and a median of $11.8 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2026: Accounts Payables increased 29.75% in 2023, then plunged 67.78% in 2026.
- Over 5 years, Accounts Payables stood at $10.8 million in 2022, then gained by 29.75% to $14.0 million in 2023, then declined by 14.1% to $12.1 million in 2024, then soared by 53.99% to $18.6 million in 2025, then plunged by 75.83% to $4.5 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $4.5 million, $18.6 million, and $13.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - | 19.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.55 Mn |
| Mar 31, 2026 | 4.49 Mn |
| Dec 31, 2025 | 18.57 Mn |
| Sep 30, 2025 | 13.83 Mn |
| Jun 30, 2025 | 13.45 Mn |
| Mar 31, 2025 | 13.93 Mn |
| Sep 30, 2024 | 12.06 Mn |
| Jun 30, 2024 | 12.51 Mn |
| Mar 31, 2024 | 13.08 Mn |
| Dec 31, 2023 | 14.04 Mn |
| Sep 30, 2023 | 10.82 Mn |
| Jun 30, 2023 | 10.91 Mn |
| Mar 31, 2023 | 11.22 Mn |
| Dec 31, 2022 | 10.82 Mn |
| Sep 30, 2022 | 11.51 Mn |
| Jun 30, 2022 | 10.59 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 9.64 Mn |
| Sep 30, 2021 | 9.23 Mn |
| Jun 30, 2021 | 8.96 Mn |